Skip to content

Prestige Consumer Healthcare Inc.

PBH · XNYS

CIK 1295947fmd_1W5M0PDAYKS2ZQ70BZ47SBPCVRManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2009 to Sep 30, 2026, 67 periods

Latest annual · FY2026

Millions
Total revenues
1,089
Gross profit
596
Operating income
309
Net income
190
Free cash flow
246

Latest quarter · Q2 FY2027

Millions
Total revenues
336
Gross profit
173
Operating income
81
Net income
25
Free cash flow
34

Daily close · PBHIEX trades only

Nov 13, 2025 to Nov 11, 2026 · 250 sessions

44.18 USD

4050607080Nov 13, 2025May 14, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2023 to FY2026
-1.2%
Revenue, 5 yearsFY2021 to FY2026
+2.9%
Net income, 5 yearsFY2021 to FY2026
+2.9%

Prestige Consumer Healthcare Inc. (PBH) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2026FY2025ChangeSource
Revenue$1.1 billion$1.1 billion-4.3%10-K 2026-05-14 · proof
Gross profit$595.6 million$634.5 million-6.1%10-K 2026-05-14 · proof
Operating income$309.4 million$336.8 million-8.1%10-K 2026-05-14 · proof
Net income$190.3 million$214.6 million-11.3%10-K 2026-05-14 · proof
Cash from operating activities$257.6 million$251.5 million+2.4%10-K 2026-05-14 · proof
Free cash flow$246.4 million$243.3 million+1.3%10-K 2026-05-14 · proof
Total assets$3.5 billion$3.4 billion+2.7%10-K 2026-05-14 · proof
Total liabilities$1.6 billion$1.6 billion+2.5%10-K 2026-05-14 · proof
Cash and cash equivalents$63.9 million$97.9 million-34.8%10-K 2026-05-14 · proof
Total debt$994 million10-Q 2026-08-06 · proof
What was Prestige Consumer Healthcare Inc. (PBH)'s revenue in fiscal 2026?
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $1.1 billion for fiscal 2026 (the year ended Mar 31, 2026), against $1.1 billion the year before (-4.3%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What was Prestige Consumer Healthcare Inc. (PBH)'s gross profit in fiscal 2026?
Prestige Consumer Healthcare Inc. (PBH) reported gross profit of $595.6 million for fiscal 2026 (the year ended Mar 31, 2026), against $634.5 million the year before (-6.1%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What was Prestige Consumer Healthcare Inc. (PBH)'s operating income in fiscal 2026?
Prestige Consumer Healthcare Inc. (PBH) reported operating income of $309.4 million for fiscal 2026 (the year ended Mar 31, 2026), against $336.8 million the year before (-8.1%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What was Prestige Consumer Healthcare Inc. (PBH)'s net income in fiscal 2026?
Prestige Consumer Healthcare Inc. (PBH) reported net income of $190.3 million for fiscal 2026 (the year ended Mar 31, 2026), against $214.6 million the year before (-11.3%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What was Prestige Consumer Healthcare Inc. (PBH)'s cash from operating activities in fiscal 2026?
Prestige Consumer Healthcare Inc. (PBH) reported cash from operating activities of $257.6 million for fiscal 2026 (the year ended Mar 31, 2026), against $251.5 million the year before (+2.4%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What was Prestige Consumer Healthcare Inc. (PBH)'s free cash flow in fiscal 2026?
Prestige Consumer Healthcare Inc. (PBH) reported free cash flow of $246.4 million for fiscal 2026 (the year ended Mar 31, 2026), against $243.3 million the year before (+1.3%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What are Prestige Consumer Healthcare Inc. (PBH)'s total assets?
As of Mar 31, 2026, Prestige Consumer Healthcare Inc. (PBH) reported total assets of $3.5 billion, against $3.4 billion a year earlier (+2.7%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What are Prestige Consumer Healthcare Inc. (PBH)'s total liabilities?
As of Mar 31, 2026, Prestige Consumer Healthcare Inc. (PBH) reported total liabilities of $1.6 billion, against $1.6 billion a year earlier (+2.5%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What are Prestige Consumer Healthcare Inc. (PBH)'s cash and cash equivalents?
As of Mar 31, 2026, Prestige Consumer Healthcare Inc. (PBH) reported cash and cash equivalents of $63.9 million, against $97.9 million a year earlier (-34.8%). Source: the 10-K filed with the SEC on May 14, 2026. SEC
What is Prestige Consumer Healthcare Inc. (PBH)'s total debt?
As of Mar 31, 2026, Prestige Consumer Healthcare Inc. (PBH) reported total debt of $994 million. Source: the 10-Q filed with the SEC on Aug 6, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PBH&period_type=annual&limit=5"

Information only, not investment advice.